FDA panel backs plan for annual COVID-19 booster, as new omicron subvariant continues to dominate in new cases
January 27, 2023 at 11:18 AM EST
An FDA panel endorsed the agency's plan for a once-a-year COVID-19 booster. And CDC data shows that XBB.1.5 continues to lead other variants in the U.S.
